Source link : https://newshealth.biz/health-news/leading-drug-fails-to-slow-alzheimers-progression/
(MedPage Today) — Alzheimer’s patients treated with the GLP-1 receptor agonist semaglutide (Rybelsus) in two phase III trials showed no significant improvement in cognitive or functional decline over 2 years compared with placebo, according to… Source link : https://www.medpagetoday.com/meetingcoverage/ctad/118850 Author : Publish date : 2025-12-05 15:57:00 Copyright for syndicated content belongs to the linked Source.
The post Leading Drug Fails to Slow Alzheimer’s Progression first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-05 15:57:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8